Stockreport

Zevra Therapeutics Refinances Existing Debt with up to $100M in Committed Capital under New Credit Facility

Zevra Therapeutics, Inc.  (ZVRA) 
PDF CELEBRATION, Fla., April 10, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today ann [Read more]